老年肝病患者血FII:CA的检测及临床意义  

Clinical significance of detection of FII:CA from the blood of senile hepatopathy patients.

作　　者：岳希全[1] 孙亚臣[1] 孙成学[1] 郝锐[1] 

机构地区：[1]北华大学附属医院感染科,吉林吉林132011

出　　处：《中国热带医学》2005年第5期1012-1012,936,共2页China Tropical Medicine

摘　　要：目的评价凝血酶原活性(FII:CA)对老年肝病患者肝功能的影响。方法应用巨齿蛇毒显色底物法检测老年肝病患者FII:CA93例及≥60岁健康老人和≤45岁健康青壮年各30例,并比较分析。结果正常老人与青壮年的FII:CA差异有显著性,老年肝病患者FII:CA明显低于健康老年人的FII:CA。结论老年肝病患者应及时检测FII:CA。Objective To evaluate the effect of plasmal prothrombin coagulative activity (factor Ⅱcoagulative activity, FII:CA) on senile hepatopathy patients. Methods FII :CA of 93 senile hepatopathy were detected with Eehis Carinalus venem method of Chromogenic aubstance (EVC). Results There were significant differences in FII:CA between the healthy old age group(≥60 years old) and young and middle age group(≤45 years old ), and FII:CA in senile hepatopathy are lower than that of healthy senile persons. Conclusion FII:CA is a good index for determination of the senile hepatopathy patients.

关 键 词：肝病 老年 凝血酶原活性(FⅡ:CA) 

分 类 号：R575[医药卫生—消化系统]